Application of KU812 cells for assessing complement activation related effects by nano(bio)materials.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
David, Christopher A Wde la Fonteyne-Blankestijn, Liset J J
Vermeulen, Jolanda P
Plant-Hately, Alexander J
Vandebriel, Rob J
Liptrott, Neill J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Application of KU812 cells for assessing complement activation related effects by nano(bio)materials.Published in
Biomed Pharmacother 2023;163:114841PMID
37167727ae974a485f413a2113503eed53cd6c53
10.1016/j.biopha.2023.114841
Scopus Count
Collections
Related articles
- Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics.
- Authors: Plant-Hately AJ, Eryilmaz B, David CAW, Brain DE, Heaton BJ, Perrie Y, Liptrott NJ
- Issue date: 2022 Nov 15
- Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
- Authors: Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, Őrfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J
- Issue date: 2014 Dec 10
- Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
- Authors: Szebeni J, Storm G
- Issue date: 2015 Dec 18
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
- Authors: Szebeni J, Muggia F, Gabizon A, Barenholz Y
- Issue date: 2011 Sep 16
- Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
- Authors: Szebeni J
- Issue date: 2001